CVE-2025-61940 affects NMIS/BioDose V22.02 and earlier versions, stemming from a design flaw where the client application uses a single, shared SQL Server user account for database access, despite client-side password authentication. This vulnerability carries a high CVSS score of 8.8, indicating that an authenticated attacker could remotely gain full control over the database (confidentiality, integrity, and availability) with low attack complexity. While no active exploitation, public exploit code, or significant community discussion has been observed, the vendor has addressed this by introducing Windows user authentication as an option in the latest version to restrict database connections.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
< 23.0CPE matchmatch criteria | cpe:2.3:a:mirion:biodose\/nmis:*:*:*:*:*:*:*:* |
CVSS version used by this source: 4.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.3 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.